Actively Recruiting
Clinical Study of Curcumin in Preventing Postoperative Adhesion of Bilateral Vocal Cords
Led by Eye & ENT Hospital of Fudan University · Updated on 2023-05-06
100
Participants Needed
1
Research Sites
190 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
To provide a novel therapy idea and method to solve the clinical problem of postoperative adhesion of bilateral vocal cords, patients enrolled in this study will be applied with curcumin on both wound sites of bilateral vocal cords after the surgery on the bilateral vocal cord endoscopically.
CONDITIONS
Official Title
Clinical Study of Curcumin in Preventing Postoperative Adhesion of Bilateral Vocal Cords
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with bilateral vocal cord diseases scheduled for endoscopic resection of bilateral vocal cord lesions
- Patients with bilateral vocal cord adhesion scheduled for endoscopic incision of bilateral vocal cord adhesion
You will not qualify if you...
- Patients with other laryngeal diseases
- Patients with cardiac and pulmonary insufficiency
- Patients unable to cooperate with timely follow-up after surgery
- Patients who refuse to sign informed consent after notification
- Patients with severe allergic diseases or history of drug allergies
- Other conditions making patient unsuitable for the clinical trial
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Eye & ENT Hospital of Fudan University
Shanghai, Shanghai Municipality, China, 200031
Actively Recruiting
Research Team
J
Jian Chen, Ph.D
CONTACT
H
Haitao Wu, Ph.D
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here